Plutux
BIO-key International, Inc. logo

BIO-key International, Inc.

BKYI
$2.82
-5.84%
2026-09-04 09:58:24 EDT+$0.00
Technology
Information Technology Services
NASDAQ
Negociación activa

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United ...

Evolución del precio

$2.82
+0.00%+$0.00
Máximo—
Mínimo—
Máx. 52s-85.7%
Vol. rel.—
Intervalo
Rango30m
Volumen—SMA5SMA10
—

Perfil de la empresa

BIO-key International, Inc. (BKYI) is a technology company focused on securing user access by linking authentication to biometrics—primarily fingerprint identity—rather than relying solely on traditional passwords. Its core business centers on identity and access management (IAM) platforms and related biometric solutions that organizations can use to authenticate users and control ...BIO-key International, Inc. (BKYI) is a technology company focused on securing user access by linking authentication to biometrics—primarily fingerprint identity—rather than relying solely on traditional passwords. Its core business centers on identity and access management (IAM) platforms and related biometric solutions that organizations can use to authenticate users and control access to systems and applications. From a product and services perspective, BIO-key offers cloud and enterprise platforms such as BIO-key PortalGuard and PortalGuard IDaaS. These are designed to enable authentication through an IAM platform and support enterprise authentication and access workflows. The company also provides biometric client and access technologies including BIO-key VST and WEB-key, supporting flexible deployment for different application environments and user experiences. In addition to software, BIO-key supplies fingerprint readers for commercial use under brands such as SidePass, SideSwipe, and EcoID II. This combination of hardware and software helps customers implement end-to-end biometric authentication systems, which can simplify procurement, integration planning, and deployment logistics compared with assembling systems from multiple vendors. BIO-key’s IAM feature set (as described) includes capabilities such as user multi-factor authentication (MFA), single sign-on (SSO), privilege entitlement, and access control. These capabilities are particularly relevant for organizations that need to strengthen account security, reduce unauthorized access risk, and enforce appropriate permissions across users, roles, and applications. Cost and BOM considerations typically arise in biometric authentication programs where customers weigh device cost, deployment effort, integration complexity, and ongoing operational needs (such as account lifecycle management and support). BIO-key’s strategy of bundling platform software with supported fingerprint hardware can reduce customer friction and time-to-deployment, though specific customer pricing and BOM details are not provided in the supplied data. Financially, the supplied ttm snapshot indicates negative profitability metrics (e.g., negative operating and net margins) and negative free cash flow figures, suggesting the company may be operating with continued investment and/or pressure from costs relative to revenue. Key liquidity/coverage ratios in the snapshot are mixed (e.g., a current ratio around 1.26), while cash flow metrics appear weak, which can be important to consider for budgeting, contract planning, and ongoing R&D commitments. Key people include Michael W. DePasquale (Chairman and CEO), with additional leadership noted such as Mira LaCous (Chief Technology Officer) and Alex Rocha (Managing Director – EMEA). BIO-key serves customers across commercial, government, and education sectors, aligning its solutions with use cases that require higher assurance authentication (including regulated or defense-related environments as referenced in the overview). Overall, BIO-key’s “identity hardening” approach focuses on making authentication more secure and user-friendly by using biometrics integrated into IAM and access control workflows—aiming to help enterprises improve security posture while maintaining usability for authorized users.
Fundación
1993
Empleados
42
CEO
Michael W. DePasquale
Nombre completo
BIO-key International, Inc.
Sector
Technology
Industria
Information Technology Services
ROE
-53.82%
Capitalización
$0.00B
Ratio corriente
1.26
WACC
17.04%
ROIC
-192.44%

Información de contacto

https://www.bio-key.com
732 359 1100
101 Crawfords Corner Road, Holmdel, NJ 07753

Acciones relacionadasInformation Technology Services

Ver todas las acciones de EE. UU. →
Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal

© Plutux Technology Limited 2026